The United States Food and Drug Administration (US FDA) conducted a pre-approval inspection at Eugia Steriles, a 100 per cent subsidiary of Eugia Pharma Specialities and a step-down subsidiary of Aurobindo Pharma situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, with five observations.
The inspection was conducted from February 10, 2025, to February 18, 2025. “The inspection concluded with 5 observations. The observations are procedural in nature and will be responded to within the stipulated time,’‘ Aurobindo Pharma said on Tuesday.